Multiple studies have indicated a positive correlation between the level of CK-18 and the occurrence of MASH, at the same time confirming its high sensitivity and specificity in the diagnosis of this stage of MASLD [34,35,36]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.